NFG
CELGZ

Next Financial Group’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Next Financial Group’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-25
Closed – – 2528
2016
Q4 		$0 Hold
25
– – ﹤0.01% 2589
2016
Q3 		$0 Buy
+25
New +$30 ﹤0.01% 2529
2014
Q4 		– Sell
-25
Closed – – 2673
2014
Q3 		$0 Hold
25
– – ﹤0.01% 2645
2014
Q2 		$0 Buy
+25
New +$69 ﹤0.01% 1263

Other funds holding CELGZ

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MSTVIM
Messner & Smith Theme Value Investment Management San Diego, California $60.3M AUM 16.8% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Next Financial Group's CELGZ Position: Q1 2017 in Review

Next Financial Group sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q1 2017, closing a stake of 25 shares.

Next Financial Group first reported a position in CELGZ in Q2 2014 and held it in 4 quarters. The position peaked at $0 in Q4 2016. 22 funds tracked by Wall St. Rank hold CELGZ as of Q1 2017.

  • Next Financial Group reported no remaining Celgene Corporation Contingent Value Rights position as of Q1 2017 after selling out during the quarter.
  • Next Financial Group sold 25 Celgene Corporation Contingent Value Rights shares in Q1 2017.
  • Next Financial Group first reported a position in Celgene Corporation Contingent Value Rights in Q2 2014 and held it in 4 quarters.
  • Next Financial Group's Celgene Corporation Contingent Value Rights position peaked at $0 in Q4 2016.
  • 22 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q1 2017.

Based on Next Financial Group's 13F filing for Q1 2017, filed 8 May 2017.